Oner Ozdemir

Assoc. Prof. Dr. Öner Özdemir was born in Alaplı, Zonguldak, Turkey on September 18, 1965. He graduated from İstanbul University İstanbul Medical School and become a medical doctor in 1989. His pediatric residency was completed at the Department of Pediatrics at the Children’s Hospital of İstanbul Medical School, Istanbul, Turkey. His clinical fellowship training was completed at the Pediatric Allergy/Immunology program at Louisiana State University Health Sciences Ctr., New Orleans, LA. A part of his clinical fellowship training was done at the pediatric allergy/immunology program in Cincinnati Children's Hospital Medical Center, Cincinnati, OH. Prof. Özdemir's research areas are as follows: LAK-cell generation and cell-mediated cytotoxicity; human mast cell development and mast cell cytotoxicity; and apoptosis -related research. He was 1st place winner of Clemens Von Pirquet Award from ACAAI at ACAAI meeting in 2005 for the best research on allergy/asthma/immunology by a fellow in training. He has 45 international and 20 national publications, as well as 85 international and 25 national presentations. Currently, he is working as Chief of Pediatrics at the third clinic associated with the division of pediatric allergy/immunology at İstanbul Medeniyet University, Göztepe Teaching and Training Hospital, Kadıköy, Istanbul, Turkey.

1books edited

1chapters authored

Latest work with IntechOpen by Oner Ozdemir

Currently there have been many armamentaria to be used in cancer treatment. This indeed indicates that the final treatment has not yet been found. It seems this will take a long period of time to achieve. Thus, cancer treatment in general still seems to need new and more effective approaches. The book "Current Cancer Treatment - Novel Beyond Conventional Approaches", consisting of 33 chapters, will help get us physicians as well as patients enlightened with new research and developments in this area. This book is a valuable contribution to this area mentioning various modalities in cancer treatment such as some rare classic treatment approaches: treatment of metastatic liver disease of colorectal origin, radiation treatment of skull and spine chordoma, changing the face of adjuvant therapy for early breast cancer; new therapeutic approaches of old techniques: laser-driven radiation therapy, laser photo-chemotherapy, new approaches targeting androgen receptor and many more emerging techniques.

Go to the book